ELAN Q4 2022 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

Q4 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$988M-11.2% YoY

Gross Profit

$410M41.5% margin

Operating Income

$27M2.7% margin

Net Income

-$54M-5.5% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

-3.7%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

-$66M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$15.5B

Total Liabilities

$8.2B

Stockholders' Equity

$7.3B

Cash & Equivalents

$345M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$988M	$1.1B	-11.2%
Gross Profit	$410M	$462M	-11.3%
Operating Income	$27M	$43M	-37.2%
Net Income	-$54M	-$104M	+48.1%

Revenue Segments

Farm Animal

$552M27%

Cattle

$469M23%

Pet Health

$416M21%

Poultry

$366M18%

Swine

$200M10%

Contract Manufacturing

$13M1%

Geographic Segments

Non-US

$552M56%

UNITED STATES

$429M44%